Anja Schroff, Klara Insulander Björk, Nishte Rassol, Julia Johansson, Torgny Lundberg, Hana Bakr, Martin Andersson, Johan Spetz, Eva Forssell-Aronsson
{"title":"Sex and age at exposure influence <sup>131</sup>I biodistribution and dosimetry in Sprague-Dawley rats.","authors":"Anja Schroff, Klara Insulander Björk, Nishte Rassol, Julia Johansson, Torgny Lundberg, Hana Bakr, Martin Andersson, Johan Spetz, Eva Forssell-Aronsson","doi":"10.1186/s13293-026-00989-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Assessing the biodistribution and absorbed dose of ¹³¹I is crucial for optimisation of radionuclide therapy, as well as for improving risk assessment following nuclear emergencies. After the Chernobyl accident, an increase in thyroid cancer among children was observed in regions affected by ¹³¹I fallout, particularly among young girls. Reasons for these age- and sex-specific differences in response to low doses of ¹³¹I are not fully understood, but variations in biodistribution and absorbed dose may be contributing factors. The aim of this study was therefore to assess the influence of sex and age at exposure on the biodistribution and dosimetry of <sup>131</sup>I.</p><p><strong>Methods: </strong>Male and female Sprague Dawley rats were internally exposed to 0.36 MBq ¹³¹I at 5 or 17 weeks of age, corresponding to young and adult exposure groups. The <sup>131</sup>I activity concentration of 16 vital tissues was measured at six time points (1-144 h post-injection) and used to estimate the mean absorbed dose to each organ. Sodium-iodide symporter (NIS) protein expression was assessed using immunohistochemistry and western blot.</p><p><strong>Results: </strong>The thyroid showed the highest ¹³¹I activity concentration at 18 h in males and 24 h in females, regardless of age. All non-thyroid tissues showed substantially lower activity concentrations, with the stomach having the second-highest levels. Statistically significant sex differences were determined in all tissues, with the most pronounced effect in the thyroid, where females consistently had higher activity concentrations compared to males. Age at exposure also impacted the biodistribution in some tissues. These differences led to pronounced variations in the absorbed dose. The absorbed dose to the thyroid ranged from 23 Gy/MBq in adult males to 100 Gy/MBq in young females. Protein quantification of NIS showed high individual variability but no clear difference between the groups.</p><p><strong>Conclusions: </strong>The results demonstrate that sex and age at exposure affect ¹³¹I biodistribution and absorbed dose in rats, particularly in the thyroid. The observed differences in absorbed dose may partly explain the variation in susceptibility to thyroid cancer in exposed populations reported after the Chernobyl accident. Further research is needed to clarify the underlying biological and mechanistic drivers of these differences.</p>","PeriodicalId":8890,"journal":{"name":"Biology of Sex Differences","volume":"17 1","pages":""},"PeriodicalIF":5.3000,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13589867/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biology of Sex Differences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13293-026-00989-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Assessing the biodistribution and absorbed dose of ¹³¹I is crucial for optimisation of radionuclide therapy, as well as for improving risk assessment following nuclear emergencies. After the Chernobyl accident, an increase in thyroid cancer among children was observed in regions affected by ¹³¹I fallout, particularly among young girls. Reasons for these age- and sex-specific differences in response to low doses of ¹³¹I are not fully understood, but variations in biodistribution and absorbed dose may be contributing factors. The aim of this study was therefore to assess the influence of sex and age at exposure on the biodistribution and dosimetry of 131I.
Methods: Male and female Sprague Dawley rats were internally exposed to 0.36 MBq ¹³¹I at 5 or 17 weeks of age, corresponding to young and adult exposure groups. The 131I activity concentration of 16 vital tissues was measured at six time points (1-144 h post-injection) and used to estimate the mean absorbed dose to each organ. Sodium-iodide symporter (NIS) protein expression was assessed using immunohistochemistry and western blot.
Results: The thyroid showed the highest ¹³¹I activity concentration at 18 h in males and 24 h in females, regardless of age. All non-thyroid tissues showed substantially lower activity concentrations, with the stomach having the second-highest levels. Statistically significant sex differences were determined in all tissues, with the most pronounced effect in the thyroid, where females consistently had higher activity concentrations compared to males. Age at exposure also impacted the biodistribution in some tissues. These differences led to pronounced variations in the absorbed dose. The absorbed dose to the thyroid ranged from 23 Gy/MBq in adult males to 100 Gy/MBq in young females. Protein quantification of NIS showed high individual variability but no clear difference between the groups.
Conclusions: The results demonstrate that sex and age at exposure affect ¹³¹I biodistribution and absorbed dose in rats, particularly in the thyroid. The observed differences in absorbed dose may partly explain the variation in susceptibility to thyroid cancer in exposed populations reported after the Chernobyl accident. Further research is needed to clarify the underlying biological and mechanistic drivers of these differences.
期刊介绍:
Biology of Sex Differences is a unique scientific journal focusing on sex differences in physiology, behavior, and disease from molecular to phenotypic levels, incorporating both basic and clinical research. The journal aims to enhance understanding of basic principles and facilitate the development of therapeutic and diagnostic tools specific to sex differences. As an open-access journal, it is the official publication of the Organization for the Study of Sex Differences and co-published by the Society for Women's Health Research.
Topical areas include, but are not limited to sex differences in: genomics; the microbiome; epigenetics; molecular and cell biology; tissue biology; physiology; interaction of tissue systems, in any system including adipose, behavioral, cardiovascular, immune, muscular, neural, renal, and skeletal; clinical studies bearing on sex differences in disease or response to therapy.